Close Menu
Home » Celsee, IncellDx to Commercialize Assays After Cancer Study Collaboration

Celsee, IncellDx to Commercialize Assays After Cancer Study Collaboration

Jan 11, 2018
|
staff reporter

NEW YORK (GenomeWeb) – Celsee said today that it has entered a co-commercialization agreement with IncellDx for several products, including a 20-marker lung cancer genomics and proteomics panel, a CTC-based screening test for breast, colorectal, prostate, and other cancers, and a cell-based NIPT assay.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

New FDA Commish Confirmed

The US Senate has confirmed Stephen Hahn as the next commissioner of the Food and Drug Administration, according to the New York Times.

That Rude Reviewer

ScienceInsider reports that rude and unprofessional paper reviewers are common and can have harmful effects.

DNA Screening for Apple Employees

CNBC reports Apple is partnering with Color Genomics to offer its employees free DNA screening for disease.

Science Studies Describe Role for Microbiome-Derived Immunity, Platform to Develop Flavivirus Vaccines

In Science this week: researchers use CRISPR tool to find gut microbiome molecules involved in immunity, and more.

What's Popular?

In Business News

  1. Bio-Rad Shares Dip Following Cyber Attack

  2. Celmatix Sues 23andMe for $100M Alleging Breach of Contract

  3. Twist Bioscience Fiscal Q4 Revenues Increase 87 Percent

  4. Twist Bioscience Teases Products for Liquid Biopsy Market, Biopharma Collaborations

    Premium

  5. Parkinson's Foundation Selects Five Sites for Genetic Testing, Counseling

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.